Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence
- PMID: 29550192
- DOI: 10.1016/j.vaccine.2018.03.014
Immune response elicited by two rBCG strains devoid of genes involved in c-di-GMP metabolism affect protection versus challenge with M. tuberculosis strains of different virulence
Abstract
Pellicles, a type of biofilm, have gathered a renewed interest in the field of tuberculosis as a structure that mimics some characteristics occurring during M. tuberculosis infection, such as antibiotic recalcitrance and chronicity of infection, and as a source of antigens for humoral response in infected guinea pigs. In other bacteria, it has been well documented that the second messenger c-di-GMP modulates the transition from planktonic cells to biofilm formation. In this work, we used the live vaccine Mycobacterium bovis BCG to determine whether deletion of genes involved in c-di-GMP metabolism would affect interaction with macrophages, capacity to induce immune response in a murine cell line and mice, and how the protein profile was modified when grown as surface pellicles. We found that deletion of the BCG1419c (Delta c-di-GMP phosphodiesterase, ΔPDE) gene, or deletion of the BCG1416c (Delta c-di-GMP diguanylate cyclase, ΔDGC) gene, altered production of TNF-α, IL-6, and IL-1β, in murine macrophages, and resulted in attenuation in intra-macrophage replication. Moreover, in addition to the improved immunogenicity of the BCGΔBCG1419c mutant already reported, deletion of the BCG1416c gene leads to increased T CD4+ and T CD8+ activation. This correlated with protection versus lethality in mice infected with the highly virulent M. tuberculosis 5186 afforded by vaccination with all the tested BCG strains, and controlled the growth of the mildly virulent M. tuberculosis H37Rv in lungs by vaccination with BCGΔBCG1419c during chronic late infection from 4 to 6 months after challenge. Furthermore, when grown as surface pellicles, a condition used to manufacture BCG vaccine, in comparison to BCG wild type, both rBCGs changed expression of antigenic proteins such as DnaK, HbhA, PstS2, 35KDa antigen, GroEL2, as well as AcpM, a protein involved in synthesis of mycolic acids, molecules relevant to modulate inflammatory responses.
Keywords: BCG; Cytokines; Pellicle; Proteome; T-cell activation; Tuberculosis.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.Vaccine. 2016 Sep 14;34(40):4763-70. doi: 10.1016/j.vaccine.2016.08.035. Epub 2016 Aug 18. Vaccine. 2016. PMID: 27546876
-
Comparison of the transcriptome, lipidome, and c-di-GMP production between BCGΔBCG1419c and BCG, with Mincle- and Myd88-dependent induction of proinflammatory cytokines in murine macrophages.Sci Rep. 2024 May 24;14(1):11898. doi: 10.1038/s41598-024-61815-8. Sci Rep. 2024. PMID: 38789479 Free PMC article.
-
BCG∆BCG1419c and BCG differ in induction of autophagy, c-di-GMP content, proteome, and progression of lung pathology in Mycobacterium tuberculosis HN878-infected male BALB/c mice.Vaccine. 2023 Jun 13;41(26):3824-3835. doi: 10.1016/j.vaccine.2023.04.065. Epub 2023 May 8. Vaccine. 2023. PMID: 37164819
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
T cells and adaptive immunity to Mycobacterium tuberculosis in humans.Immunol Rev. 2015 Mar;264(1):74-87. doi: 10.1111/imr.12274. Immunol Rev. 2015. PMID: 25703553 Review.
Cited by
-
BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis.Sci Rep. 2022 Sep 22;12(1):15824. doi: 10.1038/s41598-022-20017-w. Sci Rep. 2022. PMID: 36138053 Free PMC article.
-
BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.NPJ Vaccines. 2020 Mar 12;5(1):21. doi: 10.1038/s41541-020-0169-6. eCollection 2020. NPJ Vaccines. 2020. PMID: 32194998 Free PMC article.
-
BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells.Front Immunol. 2019 Mar 21;10:532. doi: 10.3389/fimmu.2019.00532. eCollection 2019. Front Immunol. 2019. PMID: 30949177 Free PMC article.
-
Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus.Vaccine. 2020 Aug 10;38(36):5742-5746. doi: 10.1016/j.vaccine.2020.07.003. Epub 2020 Jul 11. Vaccine. 2020. PMID: 32684497 Free PMC article. Review.
-
Mycobacterium tuberculosis Biofilms: Immune Responses, Role in TB Pathology, and Potential Treatment.Immunotargets Ther. 2024 Jul 3;13:335-342. doi: 10.2147/ITT.S455744. eCollection 2024. Immunotargets Ther. 2024. PMID: 38974843 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials